New drug duo aims to stop kidney rejection in its tracks
NCT ID NCT06918990
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 32 times
Summary
This early-stage study tests two drugs, carfilzomib and belatacept, in 25 kidney transplant recipients whose bodies are attacking the new organ. The goal is to see if the combination is safe and can reduce harmful antibodies or improve kidney function over a year. Participants will continue taking standard anti-rejection medications throughout the study.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KIDNEY TRANSPLANT REJECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Cleveland Clinic
NOT_YET_RECRUITINGCleveland, Ohio, 44195, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Duke University
NOT_YET_RECRUITINGDurham, North Carolina, 27710, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Mayo Clinic Arizona
NOT_YET_RECRUITINGPhoenix, Arizona, 85054, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
NYU Langone Health
RECRUITINGNew York, New York, 10016, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Northwestern University, Feinberg School of Medicine
NOT_YET_RECRUITINGChicago, Illinois, 60611, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
UCLA Medical Center (Site #: 71123)
NOT_YET_RECRUITINGLos Angeles, California, 90024, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Alabama Medical Center
NOT_YET_RECRUITINGBirmingham, Alabama, 35294, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Cincinnati
NOT_YET_RECRUITINGCincinnati, Ohio, 45267, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Wisconsin - Madison
NOT_YET_RECRUITINGMadison, Wisconsin, 53726, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Washington University
NOT_YET_RECRUITINGSt Louis, Missouri, 63110, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.